Interesting analysis Sooth. This company has only started to...

Interesting analysis Sooth.
This company has only started to commercialise their technology. And on some products are still in the development stage.
You seem to ignore some reasonable size companies that are in the development stage of their products that incorporate BCT tech.
Then there are the sofs that jumped on board, do you seriously think all these companies have not done their homework, not to mention the 20 odd companies that have bought into starter kits. Are they all naive? This is a big step for companies that are looking at changing a big part of their operation. I would hope they take time.
Given that you have obviously been over the past figures that show some pretty impressive growth in terms in income and product moved.
This is a company that has technology with a world market potential even if they only work the Biotech space. The figures raised and costs are chicken feed in relation to the potential.
Do you have any intell on the boards inability to drive this company forward to reach its potential? Do you think they don't have a tight reign on spending?
The current SP is conservatively taking into account the stage Bct are at. It is a speculative stock, no arguments there, but the the risk has been going down quicker than the upside has been going up.
You are not a holder but I think you might be one day when you are comfortable that this is going to fly, you are obviously happy to pay more for your entry. A lot of impressionable people see it different.